glutamine |
56-85-9 |
Levoglutamide |
L-(+)-Glutamine |
Glutamic acid amide |
Cebrogen |
Stimulina |
(S)-2,5-Diamino-5-oxopentanoic acid |
glumin |
H-Gln-OH |
Levoglutamid |
glutamic acid 5-amide |
L-Glutamide |
2-aminoglutaramic acid |
Glavamin |
Miglu-P |
Nutrestore |
Saforis |
L-2-Aminoglutaramidic acid |
L-Glutamin |
L-Glutamic acid gamma-amide |
Glumin (amino acid) |
(2S)-2-amino-4-carbamoylbutanoic acid |
L-2-Aminoglutaramic acid |
L-Glutamic acid 5-amide |
(2S)-2,5-diamino-5-oxopentanoic acid |
Glutamine (VAN) |
Levoglutamida |
Levoglutamidum |
FEMA No. 3684 |
2-Aminoglutaramic acid, L- |
GLUTAMINE, L- |
L-gln |
Pentanoic acid, 2,5-diamino-5-oxo-, (S)- |
Glutamine [USAN] |
Levoglutamidum [INN-Latin] |
2,5-Diamino-5-oxopentanoic acid, (S)- |
Levoglutamida [INN-Spanish] |
AI3-24392 |
NSC 27421 |
Levoglutamina |
L-Glutaminsaeure-5-amid |
BRN 1723797 |
L-Glutamid |
EINECS 200-292-1 |
Glutamine [USP] |
UNII-0RH81L854J |
ENDARI |
CCRIS 9428 |
L-Glutamine [JAN] |
CHEBI:18050 |
HSDB 8165 |
0RH81L854J |
MFCD00008044 |
NSC-27421 |
CHEMBL930 |
26700-71-0 |
Glutamine [USAN:USP:INN] |
gln |
DTXSID1023100 |
Glutamine (INN) |
Glutamine (USP) |
glum |
4-04-00-03038 (Beilstein Handbook Reference) |
[3H]glutamine |
GLUTAMINE [INN] |
GLUTAMINE (D) |
[14C]glutamine |
[3H]-glutamine |
Glutamine (L-Glutamine) |
[14C]-glutamine |
Levoglutamide [DCF:INN] |
GLUTAMINE (MART.) |
GLUTAMINE [MART.] |
GLUTAMINE (USP-RS) |
GLUTAMINE [USP-RS] |
glutamina |
gamma-Glutamine |
Hgln |
184161-19-1 |
GLUTAMINE (USP MONOGRAPH) |
GLUTAMINE [USP MONOGRAPH] |
l glutamine |
Glutaminsaeure-5-amid |
d(-)-glutamine |
GLUTAMINE,L- |
glutamic acid gamma-amide |
(2S)-2,5-diamino-5-oxopentanoate |
GLUTAMINE (L) |
L-Glutamic acid .gamma.-amide |
CHEBI:28300 |
glutaminum |
Glutacerebro |
Gebrogen |
Glutaven |
Memoril |
laevo-glutamine |
GlutaSolve |
L-glutamina |
AES-14 |
(C5-H10-N2-O3)x- |
3h-l-glutamine |
Q. Levoglutamide |
1wdn |
(S)-glutamine |
Sympt-X |
Nutrestore (TN) |
S(+)Glutamine |
Glutapak-10 |
Resource Glutasolve |
L-Glutamine Powder |
Cebrogen, Stimulina |
L-Glutamine,(S) |
S(+)-Glutamine |
H-Gln |
Aesgen-14 |
Endari (TN) |
L-Alanyl-L-glutamide |
Sympt-X G.I. |
Glutamic acid-5-amide |
Spectrum_000131 |
L-Glutamine [JAN] |
starbld0006818 |
L-Glutaminsaure-5-amid |
SpecPlus_000380 |
GLUTAMINE [MI] |
L-Glutamine (JP17) |
GLUTAMINE [INCI] |
Spectrum2_001377 |
Spectrum3_001416 |
Spectrum4_001709 |
Spectrum5_000418 |
GLUTAMINE [VANDF] |
L-Glutamine, 98.5% |
bmse000038 |
bmse001014 |
D01JIA |
L-GLUTAMINE [FCC] |
1-2-Aminoglutaramidic acid |
L-GLUTAMINE [FHFI] |
SCHEMBL7453 |
L-GLUTAMINE [VANDF] |
Lopac0_000549 |
BSPBio_003092 |
GTPL723 |
KBioGR_002038 |
KBioSS_000591 |
DivK1c_006476 |
SPECTRUM1500987 |
N-(2)-L-alanyl-L-glutamine |
S(+)-Glutamic acid 5-amide |
SPBio_001334 |
L-[3,4-3H(N)]glutamine |
LEVOGLUTAMIDE [WHO-DD] |
DTXCID503100 |
GTPL4633 |
GTPL4634 |
GLUTAMINE [ORANGE BOOK] |
SCHEMBL19240116 |
SCHEMBL23124227 |
BDBM18121 |
KBio1_001420 |
KBio2_000591 |
KBio2_003159 |
KBio2_005727 |
KBio3_002312 |
L-Glutamine, Cell Culture Grade |
L-GLUTAMINE [ORANGE BOOK] |
HMS3261N19 |
HMS3264C03 |
Pharmakon1600-01300018 |
Pharmakon1600-01500987 |
(S)-2,5-Diamino-5-oxopentanoate |
HY-N0390 |
(2S)-2-amino-4-carbamoylbutanoate |
Tox21_500549 |
CCG-38853 |
NSC759628 |
NSC760081 |
s1749 |
AKOS015854078 |
(S)-2-Amino-4-carbamoyl-butyric acid |
AM81759 |
CS-1947 |
DB00130 |
LP00549 |
NSC-759628 |
NSC-760081 |
SDCCGMLS-0066691.P001 |
SDCCGSBI-0050532.P005 |
(S)-2-Aminopentane-dioic acid 5-amide |
NCGC00093936-01 |
NCGC00093936-02 |
NCGC00093936-03 |
NCGC00093936-04 |
NCGC00093936-05 |
NCGC00093936-15 |
NCGC00261234-01 |
AS-11765 |
BP-13284 |
LS-71898 |
SBI-0050532.P003 |
L-Glutamine, BioUltra, >=99.5% (NT) |
EU-0100549 |
G0063 |
L-Glutamine, SAJ special grade, >=99.0% |
EN300-52640 |
C00064 |
D00015 |
D70833 |
E-6014 |
G 3126 |
M02960 |
AB00173347-03 |
AB00173347_04 |
L-Glutamine, ReagentPlus(R), >=99% (HPLC) |
L-Glutamine, Vetec(TM) reagent grade, >=99% |
A831906 |
A937790 |
L-glutamine (oral, short bowel syndrome), Emmaus |
L-Glutamine, Cell Culture Reagent (H-L-Gln-OH) |
Q181619 |
7FBA778C-D6B8-495C-BFE7-1CB8EC4ABEAB |
J-521645 |
Q-100459 |
BRD-K83896451-001-01-8 |
F0001-1471 |
L-Glutamine, certified reference material, TraceCERT(R) |
Z756440074 |
(S)-2,5-Diamino-5-oxopentanoic acid, L-Glutamic acid 5-amide |
Glutamine, United States Pharmacopeia (USP) Reference Standard |
L-glutamine (topical, chemotherapy-induced mucositis), Aesgen |
L-Glutamine, gamma-irradiated, BioXtra, suitable for cell culture |
L-glutamine (oral, sickle cell anemia/sickle beta-0 thalassemia), Emmaus |
L-Glutamine, Pharmaceutical Secondary Standard; Certified Reference Material |
L-glutamine (oral, sickle cell anemia/sickle beta-0 thalassemia), Emmaus/University of California Los Angeles |
L-Glutamine, meets USP testing specifications, cell culture tested, 99.0-101.0%, from non-animal source |
There are more than 10 synonyms. If you wish to see them all click here.
|